White blood cells levels and PCOS: Direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia

Hormones

Volumn 14, Issue 1, 2015, Pages 91-100

  Papalou, Olga ^a   Livadas, Sarantis ^a   Karachalios, Athanasios ^a   Tolia, Nikoleta ^a   Kokkoris, Panayiotis ^b   Tripolitakis, Konstantinos ^b   Diamanti Kandarakis, Evanthia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

Inflammation; Insulin resistance; Obesity; Polycystic ovary syndrome; White blood cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANDROSTENEDIONE; CHOLESTEROL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYPROGESTERONE; INSULIN; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLITROPIN BLOOD LEVEL; FREE ANDROGEN INDEX; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PROGESTERONE BLOOD LEVEL; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; BLOOD; PHYSIOLOGY; YOUNG ADULT;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; LEUKOCYTE COUNT; OBESITY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84927598773     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. 1999 J Clin Endocrinol Metab 84: 4006-4011.
2. Azziz R, Dumesic DA, Goodarzi MO, 2011 Polycystic ovary syndrome: an ancient disorder? Fertil Steril 95: 1544-1548.
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO, 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745-2749.
4. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ, 2010 The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25: 544-551.
5. Azziz R, Carmina E, Dewailly D, et al, 2006 Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91: 4237-4245.
6. Diamanti-Kandarakis E, Dunaif A, 2012 Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33: 981-1030.
7. Libby P, Theroux P, 2005 Pathophysiology of coronary artery disease. Circulation 111: 3481-3488.
8. Libby P, 2002 Inflammation in atherosclerosis. Nature 420: 868-874.
9. Kannel WB, Anderson K, Wilson PW, 1992 White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 267: 1253-1256.
10. Tedgui A, Mallat Z, 2006 Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
11. Jialal I, Devaraj S, 2001 Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 116: Suppl 1: 108-115.
12. Hulsmans M, Holvoet P, 2010 The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 14: 70-78.
13. Phelan N, O’Connor A, Kyaw Tun T, et al, 2013 Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance. Clin Endocrinol 78: 107-113.
14. Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F, 2011 Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 95: 1048-1058.
15. Orio F Jr., Palomba S, Cascella T, et al, 2005 The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome J Clin Endocrinol Metab 90: 2-5.
16. Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Millán JL, 2004 Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 89: 806-811.
17. Tarkun I, Arslan BC, Canturk Z, Türemen E, Sahin T, Duman C, 2004 Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 89: 5592-5596.
18. Diamanti-Kandarakis E, Paterakis T, Kandarakis HA, 2006 Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 1092: 175-186.
19. Christakou C, Economou F, Livadas S, et al, 2011 Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander? Hormones (Athens) 10: 292-297.
20. Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M, 2004 The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol 150: 793-798.
21. Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G, 2005 Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol 62: 37-43.
22. Diamanti-Kandarakis E, Piouka A, Livadas S, et al, 2009 Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Eur J Endocrinol 160: 847-853.
23. Orio F, Manguso F, Di Biase S, et al, 2007 Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study. Eur J Endocrinol 157: 69-73.
24. Adams J, Franks S, Polson DW, et al, 1985 Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2: 1375-1379.
25. Sathyapalan T, Atkin S, 2012 Recent advances in cardiovascular aspects of polycystic ovary syndrome. Eur J Endocrinol 166: 575-583.
26. Duleba AJ, Dokras, 2012 Is PCOS an inflammatory process? Fertil Steril 97: 7-12.
27. Sam S, Dunaif A, 2003 Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14: 365-370.
28. Herlihy AC, Kelly RE, Hogan JL, O’Connor N, Farah N, Turner MJ, 2011 Polycystic ovary syndrome and the peripheral blood white cell count. J Obstet Gynaecol 31: 242-244.
29. Shi Y, Han T, Cui L, et al, 2013 White blood cell differential counts in patients with polycystic ovary syndrome: a pilot study on Chinese women. Eur J Obstet Gynecol Reprod Biol 170: 162-164.
30. Kajaia N, Binder H, Dittrich R, et al, 2007 Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome. Eur J Endocrinol 157: 499-507.
31. Ding EL, Song Y, Manson JE, et al, 2009 Sex hormone binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361: 1152-1163.
32. Ibanez L, Jaramillo AM, Ferrer A, de Zegher F, 2005 High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception. Hum Reprod 20: 2457-2462.
33. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Müller B, 2005 Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 90: 6014-6021.
34. Alipour A, van Oostrom AJ, Izraeljan A, et al, 2008 Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol 28: 792-797.
35. Wajchenberg BL, 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738.
36. Giallauria F, Palomba S, Maresca L, et al, 2008 Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clin Endocrinol 69: 792-798.